Red Light (670 nm energy) for Peripheral Arterial Disease

Phase-Based Progress Estimates
Medical College of Wisconsin, Milwaukee, WIPeripheral Arterial Disease+2 MoreRed Light (670 nm energy) - Device
18 - 85
All Sexes
What conditions do you have?

Study Summary

This trial is testing whether a single 5 minute exposure of 670 nm light can improve blood flow in people with peripheral artery disease.

Eligible Conditions
  • Peripheral Arterial Disease
  • Vasodilation
  • Intermittent Claudication

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: Baseline, 5 min of light, and up to 1 min after discontinuation of light

Baseline and 1 min after discontinuation of light
Changes in nitric oxide metabolites
Baseline, 5 min of light, and up to 1 min after discontinuation of light
Changes in blood flow

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Red Light treatment
1 of 1

Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Red Light (670 nm energy) · No Placebo Group · N/A

Red Light treatmentExperimental Group · 2 Interventions: Red Light (670 nm energy), Octafluoropropane · Intervention Types: Device, Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 5 min of light, and up to 1 min after discontinuation of light

Who is running the clinical trial?

Medical College of WisconsinLead Sponsor
572 Previous Clinical Trials
1,155,205 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
130 Patients Enrolled for Peripheral Arterial Disease
Nicole L Lohr, MD,PHDPrincipal InvestigatorMedical College of Wisconsin

Eligibility Criteria

Age 18 - 85 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are individuals still being accepted to participate in this clinical trial?

"Per the listings on, this research project is still enrolling participants and has been since January 17th 2018. The entry was last modified on May 9th 2022." - Anonymous Online Contributor

Unverified Answer

Is this research open to elderly participants?

"The parameters for inclusion in this medical test state that applicants must be within the age range of 18 to 85. Separately, 13 trials are available specifically to minors while 247 clinical studies are tailored to those aged 65 and above." - Anonymous Online Contributor

Unverified Answer

Under what criteria are participants eligible to join this research?

"This research is actively seeking out 40 individuals, aged between 18 and 85, who are currently experiencing vasodilation. To be included in the study, patients must have been diagnosed with peripheral artery disease; recruitment will not discriminate on gender or ethnicity." - Anonymous Online Contributor

Unverified Answer

What is the total number of participants enrolled in this trial?

"Affirmative. provides information that this medical trial, which was initially published on the 17th of January 2018, is presently recruiting volunteers. The research requires 40 patients to be drawn from a single center." - Anonymous Online Contributor

Unverified Answer

What is the predominant application of Red Light (670 nm energy)?

"Through the use of Red Light (670 nm energy), medical professionals can combat echocardiography, cardiovascular diseases, and diagnostic imaging." - Anonymous Online Contributor

Unverified Answer

Are there any other investigations which have utilized Red Light (670 nm energy)?

"At present, 19 investigations of Red Light (670 nm energy) are underway with one in its third phase. Most examinations take place within Philadelphia, Pennsylvania yet there are 26 other places where the research is being conducted." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.